Skip to content

Magnesium Compartment study

Magnesium Compartment study - MaCoS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036934
Enrollment
80
Registered
2025-07-02
Start date
2025-02-21
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

magnesium status

Interventions

Group 1: 250 mg magnesium per day as magnesiumoxid for 20 weeks Group 2: 250 mg magnesium per day as magnesiumcitrate for 20 weeks Group 3: 250 mg magnesium per day as magnesiumoxid /-citrate (80/20)

Sponsors

Hermes Arzneimittel GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Voluntary participation confirmed with signature; young adults between 20 and 40 years old, BMI between 18.5 - 29.9 kg/m²

Exclusion criteria

Exclusion criteria: Phenylketonuria; Excessive alcohol consumption; Any tobacco use or any cannabis consumption; Excessive physical activity (overexercise); Competitive sports; Underweight (BMI < 18.5 kg/m²) and obesity (BMI = 30 kg/m²); Known diagnoses of atrioventricular block (AV Block); Bradyarrhythmias (bradyarrhythmias and conduction blocks); Myasthenia gravis; Severe renal insufficiency; Use of diuretics; Coagulopathy ((blood) coagulation disorder); Hemophobia (blood-injury phobia); (Oral) anticoagulants (use of anticoagulant medication); Regular intake of dietary supplements containing magnesium; (Chronic) use of glucocorticoids; Any diagnosed cardiovascular disease, metabolic disorders, or chronic inflammatory diseases requiring pharmacological treatment; (Food) intolerances to acesulfame, aspartame, xylitol, or other artificial sweeteners or sugar substitutes; Diagnosed gastrointestinal disorders (inflammatory bowel disease [IBD], celiac disease, short bowel syndrome, status post bariatric surgery, etc.); Pregnancy and breastfeeding (nursing)

Design outcomes

Primary

MeasureTime frame
Magnesium concentration in peripheral blood mononuclear cells (PBMCs) before and after 20 weeks of supplementation

Secondary

MeasureTime frame
Magnesium concentration in erythrocytes, plasma, and 24 h urine. Different gastrointestinal, psychological, muscular, and nervous complaints before and after 20 weeks of supplementation

Countries

Germany

Contacts

Public ContactSandra Habicht

Institut für Ernährungswissenschaft, Justus Liebig Universität

Sandra.D.Habicht@ernaehrung.uni-giessen.de+496419939046

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026